Cheongju, South Korea

Dong Hwee Lee

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Green Cross Holdings Corporation. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dong Hwee Lee. Retrieved from https://idiyas.com/inventor/dong-hwee-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Dong Hwee Lee in Hepatitis B Immunoglobulin Preparation

Introduction

Dong Hwee Lee is a notable inventor based in Cheongju, South Korea. He has made significant contributions to the field of immunology, particularly in the preparation of hepatitis B immunoglobulin derived from human plasma. His innovative methods have the potential to enhance the quality and efficiency of immunoglobulin production.

Latest Patents

Dong Hwee Lee holds a patent for "Methods for preparing hepatitis B immunoglobulin derived from plasma." This invention focuses on a preparation method that involves dialysis concentration of plasma protein fraction II, which contains human hepatitis B immunoglobulin. The process includes the removal of thrombus-producing materials and impurities using anion exchange resin and cation exchange resin purification techniques. This method improves the efficiency of impurity removal while maintaining a stable polymer content, resulting in high-quality hepatitis B immunoglobulin.

Career Highlights

Dong Hwee Lee is associated with Green Cross Holdings Corporation, where he continues to work on advancements in immunoglobulin preparation. His expertise and innovative approaches have positioned him as a valuable asset in the field of biotechnology.

Collaborations

He has collaborated with notable colleagues, including Dong Il Park and Yong Uk Shin, to further enhance research and development in his area of expertise.

Conclusion

Dong Hwee Lee's contributions to the preparation of hepatitis B immunoglobulin represent a significant advancement in the field of immunology. His innovative methods promise to improve the quality and efficiency of immunoglobulin production, benefiting patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…